Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Shares Outstanding (Diluted Average) (2016 - 2025)

BioCorRx (BICX) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $18.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 76.66% to $18.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Dec 2025, up 76.66% year-over-year, with the annual reading at $18.5 million for FY2025, 76.66% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $18.5 million in Q4 2025 for BioCorRx, up from $396645.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $18.5 million in Q4 2025 to a low of $396645.0 in Q3 2025.